Twitter | Pretraživanje | |
intrexon
We are a community of scientists and creative innovators working to build a safer, healthier planet, and a more promising future. (NASDAQ: )
4.999
Tweetovi
618
Pratim
3.417
Osobe koje vas prate
Tweetovi
intrexon 3. velj
completes series of transactions to solidify healthcare focus. Name changes to from and ticker symbol to :
Reply Retweet Označi sa "sviđa mi se"
intrexon 15. sij
Triple-Gene to highlight its investigational in Phase 1 for treatment of at TODAY January 15th at 11:30am PT in Franciscan B at the Hilton San Francisco Union Square
Reply Retweet Označi sa "sviđa mi se"
intrexon 14. sij
At ? Listen to Dr. Helen Sabzevari, President & CEO of , at 5pm PT in California West present on progress and 2020 look ahead OR watch live webcast here:
Reply Retweet Označi sa "sviđa mi se"
intrexon proslijedio/la je tweet
Precigen 13. sij
Join Dr. Helen Sabzevari, President and CEO of Precigen, at for her presentation on Precigen’s progress and a 2020 look ahead.
Reply Retweet Označi sa "sviđa mi se"
intrexon 9. sij
Triple-Gene to highlight advantages of its multigenic approach for treatment of at on January 15th, 2020 at 11:30AM PT at the Hilton San Francisco Union Square. Read more here:
Reply Retweet Označi sa "sviđa mi se"
intrexon proslijedio/la je tweet
Washington Business Journal 7. sij
Just four days after Germantown's Intrexon Corp. made public plans to rebrand as Precigen, its subsidiary by the same name has secured a coveted regulatory designation for its blood cancer treatment.
Reply Retweet Označi sa "sviđa mi se"
intrexon proslijedio/la je tweet
Precigen 6. sij
receives first regulatory designation for PRGN-3006 UltraCAR-T
Reply Retweet Označi sa "sviđa mi se"
intrexon 2. sij
To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To To Reflect Healthcare Focus. Read more here:
Reply Retweet Označi sa "sviđa mi se"
intrexon proslijedio/la je tweet
Precigen 20. stu
’s Tim Chan to present preclinical data from PRGN-3006 UltraCAR-T at in Orlando, FL
Reply Retweet Označi sa "sviđa mi se"
intrexon proslijedio/la je tweet
Precigen 2. pro
Dr. Helen Sabzevari, President of , will speak at the upcoming World Vaccine & Immunotherapy Congress in San Francisco. Join us! -T
Reply Retweet Označi sa "sviđa mi se"
intrexon proslijedio/la je tweet
ActoBio Therapeutics™ 2. pro
Great news from our partners at ! Enrollment is now complete for their phase 2 clinical trial of AG013 for . AG013 is an ActoBio Therapeutics Inc. candidate created on our ® platform and licensed to Oragenics. More:
Reply Retweet Označi sa "sviđa mi se"
intrexon 18. stu
subsidiary Triple-Gene presented preliminary phase 1 trial data of investigational multigenic therapeutic candidate INXN 4001 for treatment of at . Discover more: and
Reply Retweet Označi sa "sviđa mi se"
intrexon 15. stu
Discover more about Triple-Gene’s approach to address : highlights “The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure”
Reply Retweet Označi sa "sviđa mi se"
intrexon 12. stu
Intrexon Reports Third Quarter Financial Results: . to host conference call today at 11am ET to provide Precigen business and pipeline updates. Register for call here:
Reply Retweet Označi sa "sviđa mi se"
intrexon 7. stu
Intrexon subsidiary Triple-Gene announces completion of dosing in Phase 1 trial of INXN-4001, first multigenic investigational candidate for treatment of . Learn more here:
Reply Retweet Označi sa "sviđa mi se"
intrexon 4. stu
to Announce Third Quarter Financial Results on Nov 12th. to host conference call that day at 11am ET to provide Precigen business and pipeline updates. To learn more and register, click here:
Reply Retweet Označi sa "sviđa mi se"
intrexon proslijedio/la je tweet
Darling Ingredients 28. lis
Darling Ingredients and help feed the world. 'Bugging' to know how? Find out:
Reply Retweet Označi sa "sviđa mi se"
intrexon 23. lis
At ? Don’t miss Therapeutics™ CEO Pieter Rottiers presenting an overview of the innovative ActoBiotics® platform today Wednesday October 23 @ 9:15 AM PT. Read more: or follow us on LinkedIn or Twitter
Reply Retweet Označi sa "sviđa mi se"
intrexon 1. lis
At ? Don't miss Therapeutics™ CEO Pieter Rottiers' presentation at 4PM today about the innovative ActoBiotics® platform. More: or follow on Twitter or LinkedIn.
Reply Retweet Označi sa "sviđa mi se"
intrexon 26. ruj
David Witte formerly of to lead MBP Titan LLC, standalone subsidiary company of Intrexon comprising Intrexon’s Platform. Discover more: .
Reply Retweet Označi sa "sviđa mi se"